What are the AUA treatment guidelines for asymptomatic or minimally-symptomatic, metastatic castration-resistant prostate cancer (CRPC) with good performance status and without prior docetaxel chemotherapy?

Updated: Jul 31, 2017
  • Author: Bagi RP Jana, MD; more...
  • Print


Recommendations are as follows:

  • Abiraterone plus prednisone, enzalutamide, docetaxel, or sipuleucel-T

  • First-generation antiandrogen therapy or ketoconazole plus steroid or observation to patients who do not want or cannot have one of the standard therapies

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!